Global trends in Candidemia: Review of reports from 1995-2005

被引：94

作者：

Morgan J. ^{[1
]}

机构：

[1] Mycotic Disease Branch, Center for Disease Control and Prevention, Atlanta, GA 30333

来源：

Current Infectious Disease Reports | 2005年 / 7卷 / 6期

关键词：

Candida Species; Bloodstream Infection; Invasive Candidiasis; Antifungal Susceptibility; Clin Microbiol Infect;

D O I：

10.1007/s11908-005-0044-7

中图分类号：

学科分类号：

摘要：

Candida species are an important cause of health care-related bloodstream infections (BSI). Understanding the current Candida BSI incidence trends, the dominant species causing disease, and the mortality associated with this infection are important to help guide therapeutic and prophylaxis measures. In this review, trends in the incidence of Candida BSI are assessed using data extracted from reports published worldwide during 1995 to 2005. The incidence trend of Candida BSI was found to be stable for most of the reports reviewed, and Candida albicans remains the most common species causing Candida BSIs. Surveillance to monitor the burden of disease and emergence of resistance, among the general patient population and among high risk patient populations, should be continued. Copyright © 2005 by Current Science Inc.

引用

页码：429 / 439

页数：10

共 55 条

[1]

Pfaller M.A., Jones R.N., Messer S.A., Et al., National surveillance of nosocomial blood stream infection due to Candida albicans: Frequency of occurrence and antifungal susceptibility in the SCOPE program, Diagn. Microbiol. Infect. Dis., 31, pp. 327-332, (1998)

[2]

Jarvis W.R., Epidemiology of nosocomial fungal infections, with emphasis on Candida species, Clin. Infect. Dis., 20, pp. 1526-1530, (1995)

[3]

Banerjee S.N., Emori T.G., Culver D.H., Et al., Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989, Am. J. Med., 91, (1991)

[4]

Beck-Sague C.M., Jarvis W.R., Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990, J. Infect. Dis., 167, pp. 1247-1251, (1993)

[5]

Fisher-Hoch S.P., Hutwagner L., Opportunistic candidiasis: An epidemic of the 1980s, Clin. Infect. Dis., 21, pp. 897-904, (1995)

[6]

Pittet D., Wenzel R.P., Nosocomial bloodstream infections. Secular trends in rate, mortality, and contribution to total hospital deaths, Arch. Intern. Med., 155, pp. 1177-1184, (1995)

[7]

Trick W.E., Fridkin S.K., Edwards J.R., Hajjeh R.A., Et al., Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999, Clin. Infect. Dis., 35, pp. 627-630, (2002)

[8]

Marr K.A., Seidel K., Slavin M.A., Et al., Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial, Blood, 96, pp. 2055-2061, (2000)

[9]

Hobson R.P., The global epidemiology of invasive Candida infections - Is the tide turning?, J. Hosp. Infect., 55, pp. 159-168, (2003)

[10]

Karlowsky J.A., Zhanel G.G., Klym K.A., Et al., Candidemia in a Canadian tertiary care hospital from 1976 to 1996, Diagn. Microbiol. Infect. Dis., 29, pp. 5-9, (1997)

← 1 2 3 4 5 6 →